Brendan P. Eckelman - Mar 13, 2024 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Chief Scientific Officer
Signature
/s/ Kelly D. Deck, as attorney in fact for Brendan P. Eckelman
Stock symbol
INBX
Transactions as of
Mar 13, 2024
Transactions value $
-$67,062
Form type
4
Date filed
3/15/2024, 04:48 PM
Previous filing
Mar 12, 2024
Next filing
May 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Options Exercise -$67.1K -1.9K -17.14% $35.33 9.18K Mar 13, 2024 Common Stock 1.9K $33.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.